Genital Diseases, Male  >>  goserelin acetate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

33 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
goserelin acetate / Generic mfg.
NCT00002889: Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

Completed
2
180
US
flutamide, goserelin, leuprolide acetate, low-LET photon therapy
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Prostate Cancer
01/04
06/09
NCT00165399: Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Checkmark Relapse after definitive local therapy for prostate cancer; Chemo+hormone
Mar 2013 - Mar 2013: Relapse after definitive local therapy for prostate cancer; Chemo+hormone
Completed
2
62
US
Docetaxel, Estramustine, Casodex, Zoladex
Dana-Farber Cancer Institute
Adenocarcinoma of the Prostate, Prostate Cancer
12/05
12/05
NCT00167648: Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer

Completed
2
17
US
Leuprolide or goserelin, Transdermal estradiol
University of Washington, Pacific Northwest SPORE
Cancer, Prostate Neoplasms
12/06
12/06
NCT00016913: Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Completed
2
34
US
carboplatin, estramustine, paclitaxel, radiation therapy, leuprolide or goserelin acetate
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Prostate Cancer
07/07
05/08
NCT00006359: Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer

Completed
2
63
US
LHRH agonist, antiandrogen, radiation therapy, Brachytherapy boost
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Prostate Cancer
10/07
03/12
NCT00586898: Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Completed
2
36
US
GnRH, LUPRON, ZOLADEX, Ketoconazole, Nizoral, Bicalutamide, Casodex, Testosterone transdermal gel, Androgel, Estrogen transdermal patch, CLIMARA
Memorial Sloan Kettering Cancer Center
Prostate, Cancer, Hormonal Cycling
03/09
03/09
NCT00500110: Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

Completed
2
39
US
Docetaxel, Taxotere, Imatinib Mesylate, Gleevec, STI571, Leuprolide, Lupron, Goserelin Acetate, Zoladex
M.D. Anderson Cancer Center, Novartis Pharmaceuticals
Prostate Cancer
02/10
02/10
NCT00028769: S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

Completed
2
41
US
bicalutamide, estramustine, estramustine phosphate sodium, etoposide, flutamide, goserelin, leuprolide, leuprolide acetate, nilutamide, paclitaxel
Southwest Oncology Group, National Cancer Institute (NCI)
Prostate Cancer
06/10
07/11
NCT00298155: Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer

Completed
2
35
US
goserelin with dutasteride, goserelin with bicalutamide and dutasteride, goserelin with bicalutamide and dutasteride and ketoconazole
University of Washington, GlaxoSmithKline, AstraZeneca
Cancer, Prostate Neoplasms
06/10
01/14
TARGET, NCT00589472: Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Completed
2
19
US
Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Goserelin Acetate, ZDX, Zoladex, Laboratory Biomarker Analysis, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Therapeutic Conventional Surgery, Vorinostat, L-001079038, SAHA, Suberanilohydroxamic Acid, Suberoylanilide Hydroxamic Acid, Zolinza
National Cancer Institute (NCI)
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
06/10
06/10
NCT00108732: A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Hourglass Jan 2023 - Dec 2023 : Prostvac and Casodex combination (N=50) in prostate cancer
Completed
2
50
US
Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Goserelin Acetate, ZDX, Zoladex, Recombinant Fowlpox-PSA(L155)/TRICOM Vaccine, PROSTVAC-F, rFowlpox-PSA(L155)/TRICOM Vaccine, Recombinant Vaccinia-TRICOM Vaccine, rV-TRICOM, Vaccinia-TRICOM, vaccinia-TRICOM vaccine, Sargramostim, 23-L-Leucinecolony-Stimulating Factor 2, DRG-0012, Leukine, Prokine, rhu GM-CFS, Sagramostim, Sargramostatin
National Cancer Institute (NCI)
Recurrent Prostate Carcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
10/10
10/10
NCT00454571: Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Completed
2
37
US
pazopanib hydrochloride, GW786034B, Votrient, leuprolide acetate, Enantone, LEUP, Lupron, Lupron Depot, goserelin acetate, ICI-118630, ZDX, Zoladex
National Cancer Institute (NCI)
Recurrent Prostate Cancer
12/10
12/10
NCT01250717: Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Completed
2
28
US
Docetaxel, Taxotere, Dexamethasone, Decadron, Estramustine, Zoladex, goserelin acetate, Casodex, Bicalutamide, Radical Prostatectomy
Beth Israel Deaconess Medical Center, Walter Reed Army Medical Center
Prostate Cancer
05/11
05/11
NCT00666666: R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Completed
2
55
US
AT-101, R-(-)-gossypol acetic acid, Bicalutamide, Casodex, CDX, LHRH agent, Leutinizing Hormone Receptor Hormone agonist
National Cancer Institute (NCI)
Adenocarcinoma of the Prostate, Stage IV Prostate Cancer
05/11
06/12
NCT00769795: Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer

Completed
2
29
US
IMC-A12, Cixutumumab, Bicalutamide, Goserelin
University of Washington
Prostate Cancer
08/11
11/11
NCT01088529: Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Completed
2
66
US
Abiraterone Acetate, CB7630, Prednisone, LHRHa, Lupron®, leuprolide, Zoladex®, goserelin
Cougar Biotechnology, Inc.
Prostate Cancer
03/13
03/13
NCT00528866: Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Completed
2
80
Canada, US
bicalutamide, docetaxel, flutamide, LHRH agonist, 3-dimensional conformal radiation therapy, radiation therapy
Radiation Therapy Oncology Group, National Cancer Institute (NCI), NRG Oncology
Prostate Cancer
12/13
05/18
NCT00349557: Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer

Checkmark P2 data (Prostate)
Jan 2012 - Jan 2012: P2 data (Prostate)
Completed
2
18
US
bevacizumab, bicalutamide and goserelin, intensity modulated radiation therapy (IMRT)
Benaroya Research Institute, Genentech, Inc.
Prostate Cancer
 
 
NCT00081159: Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

Completed
2
80
US
Doxorubicin hydrochloride, Adriamycin PFS, Adriamycin RDF, Adriamycin, Rubex, Goserelin acetate, Zoladex, Leuprolide acetate, Lupron Depot, Zoledronic acid, Zoledronate, Zometa, orchiectomy, strontium chloride Sr, Sr-89, Strontium-89, Mestastron
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Metastatic Cancer, Prostate Cancer
09/14
09/14
NCT00658697: Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer

Checkmark ASCO-GU 2014
Jan 2014 - Jan 2014: ASCO-GU 2014
Completed
2
42
US
Docetaxel, Taxotere, Docecad, Bevacizumab, Avastin, ADT, Lupron or Zoladex, Bicalutamide, Casodex, Cosudex, Calutide, Kalumid
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Genentech, Inc.
Prostate Cancer
09/14
06/15
NCT00776594: Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Completed
2
102
US
Androgen Deprivation Therapy, ADT, bicalutamide, bevacizumab
Dana-Farber Cancer Institute, Genentech, Inc., Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Rutgers Cancer Institute of New Jersey
Prostate Cancer
12/14
09/16
NCT01076335: Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

Completed
2
40
US
Neoadjuvant Hormonal Therapy, Leuprolide Acetate, Goserelin Acetate, Docetaxel, Taxotere
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Prostate Cancer
06/15
06/15
NCT01120236: Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
211
US, Canada
Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Cixutumumab, Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12, IMC-A12, Goserelin Acetate, ZDX, Zoladex, Laboratory Biomarker Analysis, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Pharmacological Study
National Cancer Institute (NCI)
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer
06/15
08/17
NCT01750398: Bipolar Androgen-based Therapy for Prostate Cancer (BAT)

Completed
2
33
US
Testosterone cypionate, Testosterone, Goserelin, Zoladex, Leuprolide, Lupron Depot
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recurrent Prostate Cancer
06/15
06/15
NCT01023061: Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer

Completed
2
24
US
abiraterone acetate, Zytiga, prednisone, DeCortin, Deltra, leuprolide acetate, Enantone, Lupron, Lupron Depot, laboratory biomarker analysis, external beam radiation therapy, goserelin acetate, Zoladex
University of Washington, National Cancer Institute (NCI)
Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer
09/15
09/15
ASN-002-IL, NCT02107391 / 2004-002708-13 / ACTRN12619001298101: Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Completed
2
63
RoW
Dendritic Cells DCVAC/PCa, Leuprolide acetate, Lupron, Goserelin Acetate, Zoladex
SOTIO a.s., Ascend Biopharmaceuticals Ltd
Basal Cell Carcinoma, Basal Cell Nevus Syndrome (BCNS)
12/15
06/16
NCT02678520: Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients

Withdrawn
2
0
US
3-D Conformal Radiation Therapy, 3-D CRT, Intensity Modulated Radiation Therapy, IMRT, Casodex, Zoladex , Lupron, Hormone Therapy
University of Kansas Medical Center
Prostate Cancer
02/16
02/16
EMR 63325-015, NCT01496131: Tecemotide (L-BLP25) in Prostate Cancer

Completed
2
28
US
Radiation therapy, Goserelin, Cyclophosphamide, Tecemotide (L-BLP25), L-BLP25, BLP25 liposome vaccine, Epipepimut-S
EMD Serono, National Cancer Institute (NCI)
Prostate Cancer
11/16
11/16
NCT00771017: Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Withdrawn
2
0
NA
GVAX prostate cancer vaccine, bicalutamide, goserelin, leuprolide acetate
Eastern Cooperative Oncology Group, National Cancer Institute (NCI)
Prostate Cancer
 
 
NCT00003394: Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Completed
1/2
18
US
carboplatin, endocrine-modulating drug therapy, estramustine phosphate sodium, goserelin acetate, leuprolide acetate, paclitaxel
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Prostate Cancer
04/03
04/03
NCT00653757: Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

Completed
1/2
100
US
goserelin acetate, leuprolide acetate, image-guided radiation therapy, intensity-modulated radiation therapy
Mayo Clinic, National Cancer Institute (NCI)
Prostate Cancer
12/06
12/07
NCT00225420: Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Completed
1/2
23
US
docetaxel, Taxotere, leuprolide acetate, Lupron, Eligard, Viadur, Zoladex, radiation therapy
UNC Lineberger Comprehensive Cancer Center, Sanofi
Prostate Cancer
06/10
08/12
NCT01163084: Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

Terminated
1/2
10
US
Goserelin Acetate, ZDX, Zoladex, Laboratory Biomarker Analysis, Leuprolide Acetate, A-43818, Abbott 43818, Abbott-43818, Carcinil, Depo-Eligard, Eligard, Enanton, Enantone, Enantone-Gyn, Ginecrin, LEUP, Leuplin, Leuprorelin Acetate, Lucrin, Lucrin Depot, Lupron, Lupron Depot, Lupron Depot-3 Month, Lupron Depot-4 Month, Lupron Depot-Ped, Procren, Procrin, Prostap, TAP-144, Trenantone, Uno-Enantone, Viadur, Vismodegib, Erivedge, GDC-0449, Hedgehog Antagonist GDC-0449
National Cancer Institute (NCI)
Prostate Adenocarcinoma, Stage IIA Prostate Cancer AJCC v7, Stage IIB Prostate Cancer AJCC v7
06/12
06/12

Download Options